Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor?

Kim HK, Zhao C, Choi BR, Chae HJ, Kim DS, Park JK.

Dis Markers. 2013;35(6):679-85. doi: 10.1155/2013/783287. Epub 2013 Nov 6.

2.

High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.

Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.

J Pharmacol Exp Ther. 2015 Sep;354(3):302-9. doi: 10.1124/jpet.114.222372. Epub 2015 Jun 30.

3.

Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.

Zhao J, Ding W, Song N, Dong X, Di B, Peng F, Tang C.

Regul Pept. 2013 Mar 10;182:53-8. doi: 10.1016/j.regpep.2012.12.006. Epub 2013 Feb 9.

PMID:
23403244
4.

Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.

Yang T, Chen M, Sun T.

Cell Physiol Biochem. 2013;31(6):863-74. doi: 10.1159/000350104. Epub 2013 Jun 11.

5.

HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells.

Nie Y, Cui D, Pan Z, Deng J, Huang Q, Wu K.

Mol Vis. 2008 Sep 3;14:1631-8.

6.
7.

Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2.

Echeverría C, Montorfano I, Tapia P, Riedel C, Cabello-Verrugio C, Simon F.

Infect Immun. 2014 Sep;82(9):3678-86. doi: 10.1128/IAI.02158-14. Epub 2014 Jun 16. Erratum in: Infect Immun. 2016 Feb;84(2):609-10.

8.

Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.

Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE.

J Biol Chem. 2007 May 25;282(21):15534-40. Epub 2007 Mar 30.

9.

Hyperoxia and transforming growth factor β1 signaling in the post-ischemic mouse heart.

Li Y, Cai M, Sun Q, Liu Z, Cardounel AJ, Swartz HM, He G.

Life Sci. 2013 Mar 21;92(10):547-54. doi: 10.1016/j.lfs.2013.01.018. Epub 2013 Jan 24.

10.

TGF-β2 induces transdifferentiation and fibrosis in human lens epithelial cells via regulating gremlin and CTGF.

Ma B, Kang Q, Qin L, Cui L, Pei C.

Biochem Biophys Res Commun. 2014 May 16;447(4):689-95. doi: 10.1016/j.bbrc.2014.04.068. Epub 2014 Apr 19.

PMID:
24755068
12.

Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.

Mun JH, Kim YM, Kim BS, Kim JH, Kim MB, Ko HC.

Wound Repair Regen. 2014 Jan-Feb;22(1):125-33. doi: 10.1111/wrr.12136. Epub 2013 Dec 13.

PMID:
24471776
13.

Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.

Cancer Res. 2004 Aug 1;64(15):5200-11.

14.

Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.

Roehrborn CG, Andriole GL, Wilson TH, Castro R, Rittmaster RS.

Eur Urol. 2011 Feb;59(2):244-9. doi: 10.1016/j.eururo.2010.10.040. Epub 2010 Nov 4.

PMID:
21093145
15.

Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.

Piao S, Choi MJ, Tumurbaatar M, Kim WJ, Jin HR, Shin SH, Tuvshintur B, Yin GN, Song JS, Kwon MH, Lee SJ, Han JY, Kim SJ, Ryu JK, Suh JK.

J Sex Med. 2010 Oct;7(10):3385-95. doi: 10.1111/j.1743-6109.2010.01753.x.

PMID:
20233292
16.

Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.

Hu S, Yu W, Lv TJ, Chang CS, Li X, Jin J.

Mol Membr Biol. 2014 Mar-May;31(2-3):103-10. doi: 10.3109/09687688.2014.894211. Epub 2014 Mar 20.

PMID:
24650126
17.

Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.

Ingimarsson JP, Isaksson HJ, Sigbjarnarson HP, Gudmundsson J, Geirsson G.

Scand J Urol. 2014 Feb;48(1):73-8. doi: 10.3109/21681805.2013.825878. Epub 2013 Aug 7.

PMID:
23924152
18.

Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.

Li H, Yuan X, Li J, Tang X.

Curr Eye Res. 2015 Apr;40(4):386-97. doi: 10.3109/02713683.2014.925932. Epub 2014 Jun 9.

PMID:
24911914
20.

Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.

Duan WJ, Yu X, Huang XR, Yu JW, Lan HY.

Am J Pathol. 2014 Aug;184(8):2275-84. doi: 10.1016/j.ajpath.2014.04.014. Epub 2014 Jun 10.

PMID:
24925688

Supplemental Content

Support Center